BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Immune checkpoint inhibitors
1
Early identification and multidisciplinary management of immune checkpoint inhibitors associated colitis can improve patient outcomes
12/27/2024 1:37:13 PM | Browse: 45 | Download: 110
2
Clinical evaluation of sintilimab in conjunction with bevacizumab for advanced colorectal cancer with microsatellite stable-type after failure of first-line therapy
9/28/2024 4:34:28 AM | Browse: 74 | Download: 216
3
Medical dilemma: Programmed death 1 blockade (sintilimab) therapy in patients suffering from tumours combined with psoriasis
9/19/2024 12:00:22 PM | Browse: 60 | Download: 187
4
Gastric cancer liver metastasis will reduce the efficacy of immunotherapy
9/18/2024 11:53:42 AM | Browse: 52 | Download: 167
5
Immune-related adverse events associated with immune checkpoint inhibitors for advanced gastric and gastroesophageal junction cancer: A meta-analysis
2/15/2023 12:44:08 AM | Browse: 264 | Download: 962
6
Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survival
10/18/2022 8:29:59 AM | Browse: 322 | Download: 880
7
Immune checkpoint inhibitor-associated arthritis in advanced pulmonary adenocarcinoma: A case report
9/29/2022 9:17:29 AM | Browse: 339 | Download: 1002
8
Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy”
8/1/2022 9:20:54 AM | Browse: 443 | Download: 1135
9
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment
7/27/2022 1:17:37 PM | Browse: 480 | Download: 912
10
Necessity of neutrophil-to-lymphocyte ratio monitoring for hypothyroidism using nivolumab in patients with cancer
7/22/2022 9:38:18 AM | Browse: 421 | Download: 935
11
Advances and effectiveness of the immunotherapy after liver transplantation
6/27/2022 9:34:47 AM | Browse: 469 | Download: 1010
12
Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances
6/22/2022 8:29:42 AM | Browse: 461 | Download: 842
13
Recent advances in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
5/25/2022 8:33:35 AM | Browse: 386 | Download: 763
14
Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials
5/24/2022 12:41:49 PM | Browse: 392 | Download: 632
15
Neoadjuvant treatment in non-small cell lung cancer: New perspectives with the incorporation of immunotherapy
5/24/2022 12:41:49 PM | Browse: 397 | Download: 857
16
Tsunami of immunotherapy reaches mesothelioma
4/22/2022 8:49:02 AM | Browse: 403 | Download: 776
17
Anti-programmed death 1 antibody in the treatment of coexistent Mycobacterium fortuitum and lung cancer: A case report
4/21/2022 11:35:30 AM | Browse: 291 | Download: 665
18
Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy
2/23/2022 3:51:55 PM | Browse: 426 | Download: 1235
19
Tumor-related cytokine release syndrome in a treatment-naïve patient with lung adenocarcinoma: A case report
2/11/2022 5:55:20 AM | Browse: 368 | Download: 926
20
Update on the treatment of metastatic renal cell carcinoma
1/22/2022 6:17:12 AM | Browse: 419 | Download: 668
21
Targets of immunotherapy for hepatocellular carcinoma: An update
1/21/2022 8:16:14 AM | Browse: 418 | Download: 777
22
Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
1/11/2022 12:11:23 AM | Browse: 435 | Download: 1015
23
New era of electrochemotherapy in treatment of liver tumors in conjunction with immunotherapies
12/24/2021 9:48:20 AM | Browse: 404 | Download: 705
24
Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification
12/17/2021 8:56:01 AM | Browse: 483 | Download: 1027
25
Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival
11/6/2021 4:43:07 AM | Browse: 565 | Download: 1120
26
Dynamic changes in the radiologic manifestation of a recurrent checkpoint inhibitor related pneumonitis in a non-small cell lung cancer patient: A case report
10/21/2021 8:44:04 AM | Browse: 414 | Download: 799
27
Immune checkpoint inhibitor-related hepatotoxicity: A review
8/25/2021 2:11:51 AM | Browse: 577 | Download: 1073
28
Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease
8/14/2021 11:08:13 AM | Browse: 601 | Download: 864
29
Current cancer therapies and their influence on glucose control
7/12/2021 5:45:28 AM | Browse: 507 | Download: 1101
30
Efficacy of artificial liver support system in severe immune-associated hepatitis by camrelizumab: A case report and review of literature
5/26/2021 9:58:02 AM | Browse: 487 | Download: 988
31
Atezolizumab-induced anaphylactic shock in a patient with hepatocellular carcinoma undergoing immunotherapy: A case report
5/14/2021 9:21:56 AM | Browse: 514 | Download: 1284
32
Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic review
1/7/2021 10:14:28 AM | Browse: 534 | Download: 906
33
Practice change in the management of metastatic urothelial carcinoma after ASCO 2020
12/18/2020 12:27:09 PM | Browse: 594 | Download: 1201
34
Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis
11/26/2020 8:54:27 AM | Browse: 675 | Download: 1200
35
Deep diving in the PACIFIC: Practical issues in stage III non-small-cell lung cancer to avoid shipwreck
11/18/2020 2:20:37 PM | Browse: 746 | Download: 1242
36
Steroid-responsive pancreatitides
8/25/2020 9:45:46 AM | Browse: 684 | Download: 1420
37
Severe steroid refractory gastritis induced by Nivolumab: A case report
4/28/2020 8:04:31 AM | Browse: 923 | Download: 1494
38
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
8/7/2019 7:09:17 AM | Browse: 970 | Download: 1443
39
Antibiotics and immunotherapy in gastrointestinal tumors: friend or foe?
6/6/2019 5:44:00 PM | Browse: 947 | Download: 1637
40
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
5/28/2019 9:29:42 AM | Browse: 971 | Download: 1734
41
Immune checkpoint inhibitor-induced colitis: A comprehensive review
2/26/2019 9:05:11 AM | Browse: 845 | Download: 1349
42
Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
9/20/2018 2:33:54 AM | Browse: 947 | Download: 1525
43
Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer
8/27/2018 7:22:43 AM | Browse: 1111 | Download: 1403
44
Immunotherapies in sarcoma: Updates and future perspectives
4/7/2017 8:24:12 AM | Browse: 1070 | Download: 1392
45
Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography?
2/27/2017 6:19:00 PM | Browse: 1026 | Download: 1442
46
From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis
2/8/2017 3:24:00 PM | Browse: 1048 | Download: 1480
47
Immune checkpoint therapy for pancreatic cancer
11/18/2016 3:13:00 PM | Browse: 1112 | Download: 1361
48
Immunobiology of hepatocarcinogenesis: Ways to go or almost there?
8/10/2016 3:41:00 PM | Browse: 1257 | Download: 1577
49
Potentiality of immunotherapy against hepatocellular carcinoma
9/28/2015 11:46:00 AM | Browse: 1086 | Download: 1815
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345